CoChat

Soluble γ-Secretase Modulators Selectively Inhibit the Production of the 42-Amino Acid Amyloid β Peptide Variant and Augment the Production of Multiple Carboxy-Truncated Amyloid β Species

Open access
Wagner, Steven L., Zhang, Can, Cheng, Soan, Nguyen, Phuong, Zhang, Xulun, Rynearson, Kevin D., Wang, Rong, Li, Yueming, Sisodia, Sangram S., Mobley, William C., Tanzi, Rudolph E. · 2014 · Biochemistry
Cited by 50

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is characterized pathologically by an abundance of extracellular neuritic plaques composed primarily of the 42-amino acid amyloid β peptide variant (Aβ42). In the majority of familial AD (FAD) cases, e.g., those harboring mutations in presenilin 1 (PS1), there is a relative increase in the levels of Aβ42 compared to the levels of Aβ40. We previously reported the characterization of a series of aminothiazole-bridged aromates termed aryl aminothiazole γ-secretase modulators or AGSMs [Kounnas, M. Z., et al. (2010) Neuron 67, 769-780] and showed their potential for use in the treatment of FAD [Wagner, S. L., et al. (2012) Arch. Neurol. 69, 1255-1258]. Here we describe a series of GSMs with physicochemical properties improved compared to those of AGSMs. Specific heterocycle replacements of the phenyl rings in AGSMs provided potent molecules with improved aqueous solubilities. A number of these soluble γ-secretase modulators (SGSMs) potently lowered Aβ42 levels without inhibiting proteolysis of Notch or causing accumulation of amyloid precursor protein carboxy-terminal fragments, even at concentrations approximately 1000-fold greater than their IC50 values for reducing Aβ42 levels. The effects of one potent SGSM on Aβ peptide production were verified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, showing enhanced production of a number of carboxy-truncated Aβ species. This SGSM also inhibited Aβ42 peptide production in a highly purified reconstituted γ-secretase in vitro assay system and retained the ability to modulate γ-secretase-mediated proteolysis in a stably transfected cell culture model overexpressing a human PS1 mutation validating the potential for use in FAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/bi401537v

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Fleisher A. S., 2008, Arch. Neurol., 65, 1031, 10.1001/archneur.65.8.1031 · DOI · Paper page
  2. Coric V., 2012, Arch. Neurol., 69, 1430, 10.1001/archneurol.2012.2194 · DOI · Paper page
  3. Olson R. E., 2007, Annu. Rep. Med. Chem., 42, 27
  4. Tomita T., 2009, Expert Rev. Neurother., 9, 661, 10.1586/ern.09.24 · DOI · Paper page
  5. Kumar-Singh S., 2006, Hum. Mutat., 27, 686, 10.1002/humu.20336 · DOI · Paper page
  6. Crump C. J., 2013, Biochemistry, 52, 3197, 10.1021/bi400377p · DOI · Paper page
  7. Edbauer D., 2003, Nat. Cell Biol., 5, 486, 10.1038/ncb960 · DOI · Paper page
  8. Takasugi N., 2003, Nature, 422, 438, 10.1038/nature01506 · DOI · Paper page
  9. Haass C., 2007, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
  10. Wakabayashi T., 2008, Physiology, 23, 194, 10.1152/physiol.00009.2008 · DOI · Paper page
  11. Kopan R., 2004, Nat. Rev. Mol. Cell Biol., 5, 486, 10.1038/nrm1406 · DOI · Paper page
  12. Kukar T. L., 2008, Nature, 453, 925, 10.1038/nature07055 · DOI · Paper page
  13. Kounnas M. Z., 2010, Neuron, 67, 769, 10.1016/j.neuron.2010.08.018 · DOI · Paper page
  14. Wagner S. L., 2012, Arch. Neurol., 69, 1255, 10.1001/archneurol.2012.540 · DOI
  15. Shelton C. C., 2009, Mol. Neurodegener., 4, 22, 10.1186/1750-1326-4-22 · DOI
  16. Chau D.-M., 2012, J. Biol. Chem., 287, 17288, 10.1074/jbc.M111.300483 · DOI · Paper page
  17. Page R. M., 2008, J. Biol. Chem., 283, 677, 10.1074/jbc.M708754200 · DOI · Paper page
  18. Oehlrich D., 2011, J. Med. Chem., 54, 669, 10.1021/jm101168r · DOI · Paper page
  19. Bertram L., 2012, Prog. Mol. Biol. Transl. Sci., 107, 79, 10.1016/B978-0-12-385883-2.00008-4 · DOI · Paper page
  20. Kretner B., 2011, J. Biol. Chem., 286, 15240, 10.1074/jbc.M110.213587 · DOI · Paper page
  21. Okochi M., 2006, J. Biol. Chem., 281, 7890, 10.1074/jbc.M513250200 · DOI · Paper page
  22. Page R. M., 2010, J. Biol. Chem., 285, 17798, 10.1074/jbc.M110.103283 · DOI · Paper page
  23. Yin Y. L., 2007, J. Biol. Chem., 282, 23639, 10.1074/jbc.M704601200 · DOI · Paper page
  24. Ebke A., 2011, J. Biol. Chem., 286, 37181, 10.1074/jbc.C111.276972 · DOI · Paper page
  25. Crump C. J., 2012, Bioorg. Med. Chem. Lett., 22, 2997, 10.1016/j.bmcl.2012.02.027 · DOI
  26. Crump C. J., 2011, ACS Chem. Neurosci., 2, 705, 10.1021/cn200098p · DOI · Paper page

Cited by

See all 50

Metadata

Authors
Wagner, S. L., Zhang, C., Cheng, S., Nguyen, P., Zhang, X., Rynearson, K. D., Wang, R., Li, Y., Sisodia, S. S., Mobley, W. C., & Tanzi, R. E.
Venue
Biochemistry
Published
2014-01-22
Volume
53
Issue
4
Pages
702-713
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2014773623
Cited by
50
References
9
FWCI
4.86
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.